Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Health & Fitness
Sports
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts114/v4/51/c6/1a/51c61a09-5394-8f11-7d09-fb1a13741255/mza_7549533014145446674.jpg/600x600bb.jpg
State of Possible Podcast
MassBio
5 episodes
6 months ago
A unique podcast that will feature candid, timely, and thoughtful conversations between MassBio’s President & CEO, Bob Coughlin, and a collection of the best and brightest minds in the global life sciences sector.
Show more...
Life Sciences
Business,
News,
Business News,
Entrepreneurship,
Science
RSS
All content for State of Possible Podcast is the property of MassBio and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A unique podcast that will feature candid, timely, and thoughtful conversations between MassBio’s President & CEO, Bob Coughlin, and a collection of the best and brightest minds in the global life sciences sector.
Show more...
Life Sciences
Business,
News,
Business News,
Entrepreneurship,
Science
Episodes (5/5)
State of Possible Podcast
2021 Biotech Outlook: Looking Back to Look Ahead
2020 was a rollercoaster year for the biopharma industry. It was also the year the entire industry changed; from a global response to a worldwide pandemic and an unprecedented effort around vaccine development, consideration of a new drug development model, and the emergence of new opportunities that will continue to propel the industry forward. Podcast … Continue reading 2021 Biotech Outlook: Looking Back to Look Ahead →
Show more...
4 years ago
36 minutes 26 seconds

State of Possible Podcast
The Unprecedented Nature of COVID-19 Vaccine Development & Distribution
The COVID-19 pandemic remains the number one health concern around the globe as we await approval of multiple vaccines. There are still many unanswered questions and challenges that lie ahead for the biopharma industry, health stakeholders, and government, particularly around development, prioritization, and distribution of the vaccines. Podcast host Bob Coughlin and his guests, Clement … Continue reading The Unprecedented Nature of COVID-19 Vaccine Development & Distribution →
Show more...
4 years ago
30 minutes 31 seconds

State of Possible Podcast
How Biopharma & Providers Can Work Together to Address Health Inequities
COVID-19 has put a spotlight on health inequities in our country, with minority populations being impactd at a disproportionate rate. In this episode, host Bob Coughlin and his guests, Kate Walsh, President and CEO at Boston Medical Center and Chirfi Guindo, Executive Vice President, Head of Global Product Strategy & Commercialization at Biogen will discuss … Continue reading How Biopharma & Providers Can Work Together to Address Health Inequities →
Show more...
5 years ago
31 minutes 43 seconds

State of Possible Podcast
State of the Biopharma Industry
Dr. Michelle McMurry-Heath, President & CEO of BIO, and John Maraganore, CEO of Alnylam, join Bob Coughlin, President & CEO of MassBio and a leading voice for the biotechnology industry, to discuss the biopharma industry’s response to COVID-19, its efforts to reduce health inequities, and more. In this episode, the three shed light on the … Continue reading State of the Biopharma Industry →
Show more...
5 years ago
39 minutes

State of Possible Podcast
Trailer -State of Possible Podcast
The State of Possible is more than a catchy business slogan. It’s both a vision and call to action from the Massachusetts Biotechnology Council. And now it’s also a podcast. The State of Possible Podcast with Bob Coughlin is a new, monthly podcast featuring MassBio’s President and CEO in thought-provoking conversation with some of the … Continue reading Trailer -State of Possible Podcast →
Show more...
5 years ago

State of Possible Podcast
A unique podcast that will feature candid, timely, and thoughtful conversations between MassBio’s President & CEO, Bob Coughlin, and a collection of the best and brightest minds in the global life sciences sector.